A previous study reported that IGF2BP1 could retain the stability of MYC mRNA in BC cells, by increasing the binding of IGF2BP1 with the m6A-modified MYC mRNA of the coding region instability determinant [36, 37]. This evidence concerns the gene MYC and breast cancer.